Ignite Creation Date:
2025-12-24 @ 4:19 PM
Ignite Modification Date:
2026-01-02 @ 6:50 AM
Study NCT ID:
NCT07152366
Status:
RECRUITING
Last Update Posted:
2025-09-03
First Post:
2025-06-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy and Safety of Sequential Hormone Therapy and Tetuzumab Therapy in Patients With Moderate to Severe TAO in the Active Stage After Glucocorticoid Treatment.
Sponsor:
Shanghai Changzheng Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-04-15
Start Date Type:
ACTUAL
Primary Completion Date:
2027-05-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2035-04-15
Completion Date Type:
ESTIMATED
First Submit Date:
2025-06-21
First Submit QC Date:
None
Study First Post Date:
2025-09-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-31
Last Update Post Date:
2025-09-03
Last Update Post Date Type:
ESTIMATED